Influenza Diagnostics Global Market Opportunities And Strategies To 2031

Jul 2022| TBR1043D| TBRC (Publisher)

Report Highlights

Including: 1) By Traditional Diagnostic Tests: Rapid Influenza Diagnostics Tests (RIDT); Viral Culture; DFA; Serological Assays; Other Traditional Diagnostic Tests
2) By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR); Isothermal Nucleic Acid Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Other Isothermal Nucleic Acid Amplification Tests; Other Molecular Diagnostic Tests
3) By End User: Hospitals And Clinical Laboratories; Diagnostic Reference Laboratories; Academic/Research Institutes; Other End Users
Covering: Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Becton, Dickinson and Company; Thermo Fisher Scientific Inc.; Quidel Corp

Influenza Diagnostics Global Market Opportunities And Strategies To 2031 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global influenza diagnostics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description:
Where is the largest and fastest growing market for influenza diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The influenza diagnostics market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider influenza diagnostics market; and compares it with other markets.

The report covers the following chapters

  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction – This section gives the segmentation of the influenza diagnostics market by geography, by traditional diagnostic tests, by molecular diagnostic tests and by end user covered in this report.
  • Market Characteristics – The market characteristics section of the report defines and explains influenza diagnostics market. This chapter also defines and describes goods and related services covered in the report.
  • Trends And Strategies – This chapter describes the major trends shaping the global influenza diagnostics market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Impact of COVID-19 – This section describes the impact of COVID-19 on the influenza diagnostics market.
  • Global Market Size And Growth – This section contains the global historic (2016-2021) and forecast (2021-2026, 2031) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
  • Regional Analysis – This section contains the historic (2016-2021), forecast (2021-2026, 2031) market value and growth and market share comparison by region.
  • Segmentation – This section contains the market values (2016-2021, 2021-2026, 2031) and analysis for different segments in the market.
  • Regional Market Size and Growth – This section contains the region’s market size (2021), historic and forecast (2021-2026, 2031) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).
  • Competitive Landscape – This section covers details on the competitive landscape of the global influenza diagnostics market, estimated market shares and company profiles for the leading players.
  • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for influenza diagnostics providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Frequently Asked Questions (FAQs)

Scope

Markets Covered:

  • By Traditional Diagnostic Tests: Rapid Influenza Diagnostics Tests (RIDT); Viral Culture; DFA; Serological Assays; Other Traditional Diagnostic Tests
  • By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR); Isothermal Nucleic Acid Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Other Isothermal Nucleic Acid Amplification Tests; Other Molecular Diagnostic Tests
  • By End User: Hospitals And Clinical Laboratories; Diagnostic Reference Laboratories; Academic/Research Institutes; Other End Users

Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Becton, Dickinson and Company; Thermo Fisher Scientific Inc.; Quidel Corp

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; influenza diagnostics indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Table 2 : Global Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 3 : Global Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 4 : Global Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 5 : Global Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 6 : Global Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 7 : Global Influenza Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 8 : Global Influenza Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 9 : Global Influenza Diagnostics Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 10 : Global Influenza Diagnostics Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 11 : Global Influenza Diagnostics Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 12 : Global Influenza Diagnostics Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 13 : Asia-Pacific GDP Per Capita, By Country, 2016-2021, $
  • Table 14 : Asia-Pacific Population By Age Group, By Country, 2016-2026, Thousands
  • Table 15 : Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 16 : Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 17 : Asia-Pacific Healthcare Services, By Country, 2016-2026, $ Billion
  • Table 18 : Asia-Pacific Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Table 19 : Asia-Pacific Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 20 : Asia-Pacific Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 21 : Asia-Pacific Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 22 : Asia-Pacific Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 23 : Asia-Pacific Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 24 : China GDP Per Capita, 2016-2021, $
  • Table 25 : China Population By Age Group, 2016-2026, Thousands
  • Table 26 : China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 27 : China Healthcare Services, 2016-2026, $ Billion
  • Table 28 : China Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Table 29 : China Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 30 : China Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 31 : China Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 32 : China Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 33 : China Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 34 : India Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Table 35 : India Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 36 : India Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 37 : India Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 38 : India Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 39 : India Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 40 : Japan Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Table 41 : Japan Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 42 : Japan Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 43 : Japan Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 44 : Japan Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 45 : Japan Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 46 : Australia Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Table 47 : Australia Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 48 : Australia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 49 : Australia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 50 : Australia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 51 : Australia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 52 : Indonesia Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Table 53 : Indonesia Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 54 : Indonesia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 55 : Indonesia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 56 : Indonesia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 57 : Indonesia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 58 : South Korea Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Table 59 : South Korea Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 60 : South Korea Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 61 : South Korea Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 62 : South Korea Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 63 : South Korea Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 64 : Western Europe GDP Per Capita, By Country, 2016-2021, $
  • Table 65 : Western Europe Population By Age Group, By Country, 2016-2026, Thousands
  • Table 66 : Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 67 : Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 68 : Western Europe Healthcare Services, By Country, 2016-2026, $ Billion
  • Table 69 : Western Europe Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Table 70 : Western Europe Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 71 : Western Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 72 : Western Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 73 : Western Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 74 : Western Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 75 : UK Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Table 76 : UK Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 77 : UK Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 78 : UK Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 79 : UK Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 80 : UK Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 81 : Germany Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Table 82 : Germany Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 83 : Germany Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 84 : Germany Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 85 : Germany Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 86 : Germany Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 87 : France Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Table 88 : France Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 89 : France Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 90 : France Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 91 : France Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 92 : France Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 93 : Eastern Europe GDP Per Capita, By Country, 2016-2021, $
  • Table 94 : Eastern Europe Population By Age Group, By Country, 2016-2026, Thousands
  • Table 95 : Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 96 : Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 97 : Eastern Europe Healthcare Services, By Country, 2016-2026, $ Billion
  • Table 98 : Eastern Europe Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Table 99 : Eastern Europe Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 100 : Eastern Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 101 : Eastern Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 102 : Eastern Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 103 : Eastern Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 104 : Russia Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Table 105 : Russia Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 106 : Russia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 107 : Russia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 108 : Russia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 109 : Russia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 110 : North America GDP Per Capita, By Country, 2016-2021, $
  • Table 111 : North America Population By Age Group, By Country, 2016-2026, Thousands
  • Table 112 : North America Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 113 : North America Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 114 : North America Healthcare Services, By Country, 2016-2026, $ Billion
  • Table 115 : North America Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Table 116 : North America Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 117 : North America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 118 : North America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 119 : North America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 120 : North America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 121 : USA GDP Per Capita, 2016-2021, $
  • Table 122 : USA Population By Age Group, 2016-2026, Thousands
  • Table 123 : USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 124 : USA Healthcare Services, By Country, 2016-2026, $ Billion
  • Table 125 : USA Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Table 126 : USA Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 127 : USA Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 128 : USA Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 129 : USA Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 130 : USA Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 131 : South America GDP Per Capita, By Country, 2016-2021, $
  • Table 132 : South America Population By Age Group, By Country, 2016-2026, Thousands
  • Table 133 : South America Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 134 : South America Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 135 : South America Healthcare Services, By Country, 2016-2026, $ Billion
  • Table 136 : South America Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Table 137 : South America Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 138 : South America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 139 : South America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 140 : South America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 141 : South America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 142 : Brazil Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Table 143 : Brazil Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 144 : Brazil Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 145 : Brazil Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 146 : Brazil Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 147 : Brazil Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 148 : Middle East GDP Per Capita, By Country, 2016-2021, $
  • Table 149 : Middle East Population By Age Group, By Country, 2016-2026, Thousands
  • Table 150 : Middle East Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 151 : Middle East Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 152 : Middle East Healthcare Services, By Country, 2016-2026, $ Billion
  • Table 153 : Middle East Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Table 154 : Middle East Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 155 : Middle East Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 156 : Middle East Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 157 : Middle East Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 158 : Middle East Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 159 : Africa GDP Per Capita, By Country, 2016-2021, $
  • Table 160 : Africa Population By Age Group, By Country, 2016-2026, Thousands
  • Table 161 : Africa Public Healthcare Expenditure, 2015-2020, $ Billion
  • Table 162 : Africa Private Healthcare Expenditure, 2015-2020, $ Billion
  • Table 163 : Africa Healthcare Services, By Country, 2016-2026, $ Billion
  • Table 164 : Africa Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Table 165 : Africa Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Table 166 : Africa Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 167 : Africa Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 168 : Africa Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Table 169 : Africa Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
  • Table 170 : Global Influenza Diagnostics market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Table 171 : Abbott – Financial Performance, $ Billion
  • Table 172 : Roche – Financial Performance, $ Billion
  • Table 173 : BD – Financial Performance, $ Billion
  • Table 174 : Thermo Fisher– Financial Performance, $ Billion
  • Table 175 : Quidel – Financial Performance, $ Billion
  • Table 176 : Global Influenza Diagnostics Market Size Gain ($ Million), 2021 – 2026, By Country
  • Table 177 : Global Influenza Diagnostics Market Size Gain ($ Million), Segmentation By Traditional Diagnostic Tests, 2021 – 2026
  • Table 178 : Global Influenza Diagnostics Market Size Gain ($ Million), Segmentation By Molecular Diagnostic Tests, 2021 – 2026
  • Table 179 : Global Influenza Diagnostics Market Size Gain ($ Million), Segmentation By End-User, 2021 – 2026
  • Table 180 : Influenza Diagnostics - Market Data Sources
  • Figure 1 : Global Influenza Diagnostics Market Segmentation By Traditional Diagnostic Tests
  • Figure 2 : Global Influenza Diagnostics Market Segmentation By Molecular Diagnostic Tests
  • Figure 3 : Global Influenza Diagnostics Market Segmentation By End-User
  • Figure 4 : Global Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Figure 5 : Global Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 6 : Global Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 7 : Global Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 8 : Global Influenza Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 9 : Global Influenza Diagnostics Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 10 : Global Influenza Diagnostics Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 11 : Asia-Pacific Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Figure 12 : Asia-Pacific Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 13 : Asia-Pacific Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 14 : Asia-Pacific Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 15 : China Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Figure 16 : China Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 17 : China Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 18 : China Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 19 : India Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Figure 20 : India Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 21 : India Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 22 : India Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 23 : Japan Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Figure 24 : Japan Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 25 : Japan Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 26 : Japan Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 27 : Australia Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Figure 28 : Australia Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 29 : Australia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 30 : Australia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 31 : Indonesia Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Figure 32 : Indonesia Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 33 : Indonesia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 34 : Indonesia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 35 : South Korea Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Figure 36 : South Korea Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 37 : South Korea Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 38 : South Korea Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 39 : Western Europe Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Figure 40 : Western Europe Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 41 : Western Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 42 : Western Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 43 : UK Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Figure 44 : UK Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 45 : UK Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 46 : UK Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 47 : Germany Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Figure 48 : Germany Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 49 : Germany Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 50 : Germany Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 51 : France Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Figure 52 : France Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 53 : France Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 54 : France Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 55 : Eastern Europe Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Figure 56 : Eastern Europe Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 57 : Eastern Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 58 : Eastern Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 59 : Russia Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Figure 60 : Russia Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 61 : Russia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 62 : Russia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 63 : North America Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Figure 64 : North America Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 65 : North America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 66 : North America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 67 : USA Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Figure 68 : USA Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 69 : USA Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 70 : USA Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 71 : South America Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Figure 72 : South America Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 73 : South America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 74 : South America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 75 : Brazil Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Figure 76 : Brazil Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 77 : Brazil Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 78 : Brazil Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 79 : Middle East Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Figure 80 : Middle East Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 81 : Middle East Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 82 : Middle East Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 83 : Africa Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
  • Figure 84 : Africa Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
  • Figure 85 : Africa Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 86 : Africa Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
  • Figure 87 : Global Influenza Diagnostics market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Figure 88 : Abbott – Financial Performance, $ Billion
  • Figure 89 : Roche – Financial Performance, $ Billion
  • Figure 90 : BD – Financial Performance, $ Billion
  • Figure 91 : Thermo Fisher– Financial Performance, $ Billion
  • Figure 92 : Quidel – Financial Performance, $ Billion

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Influenza Diagnostic Global Market Report 2022

  • Date - Feb 2022
  • Code - TBR1043C

Including: 1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT); Viral Culture; DFA; Serological assays; Others
2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR); Isothermal Nucleic Acid Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Other Isothermal Nucleic Acid Amplification Tests; Other ...

Influenza Diagnostic Global Market Report 2021: COVID-19 Implications And Growth To 2030

  • Date - Sep 2021
  • Code - TBR1043B

Including: 1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT); Viral Culture; DFA; Serological assays; Othes
2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR); Isothermal Nucleic Acid Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Other Isothermal Nucleic Acid Amplification Tests; Other ...

Influenza Diagnostic Global Market Report 2020-30: Covid 19 Implications and Growth

  • Date - Jul 2020
  • Code - TBR1043A

Including: 1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT); Viral Culture; DFA; Serological assays; Others
2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR); Isothermal Nucleic Acid Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Other Isothermal Nucleic Acid Amplification Tests; Other Molecular ...

The Business Research Company
Price: $5000

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS